“…The current study has strengths and limitations. Among the strengths, we expanded the list of nutrients used in previous papers of our group on several cancer sites (e.g., [ 43 , 44 , 45 ]) to include nutrients such as EPA, DHA, lignans, flavonoids, phenolic acids, and tyrosols, which are likely to be involved in RA development or disease activity [ 6 , 7 , 8 , 9 , 13 , 14 ]. Other nutrients could be added to our list.…”